HIV and hepatitis C among injecting drug users.
作者信息
Coutinho R A
出版信息
BMJ. 1998 Aug 15;317(7156):424-5. doi: 10.1136/bmj.317.7156.424.
Abstract
摘要
相似文献
1
HIV and hepatitis C among injecting drug users.注射吸毒者中的艾滋病毒和丙型肝炎
BMJ. 1998 Aug 15;317(7156):424-5. doi: 10.1136/bmj.317.7156.424.
2
Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.预防注射吸毒者感染丙型肝炎病毒：机会之窗狭窄。
J Infect Dis. 2011 Mar 1;203(5):571-4. doi: 10.1093/infdis/jiq111. Epub 2011 Jan 31.
3
Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.澳大利亚的注射吸毒情况：针头/注射器项目证明了自身价值，但丙型肝炎感染率仍在上升。
Med J Aust. 2003 Jul 21;179(2):119; author reply 119.
4
HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.再谈艾滋病毒：预防血源性病毒在注射吸毒者中的传播。
Aust J Public Health. 1994 Sep;18(3):239-41. doi: 10.1111/j.1753-6405.1994.tb00236.x.
5
Once more unto the breach: controlling hepatitis C in injecting drug users.
Addiction. 1996 Feb;91(2):181-4. doi: 10.1111/j.1360-0443.1996.tb03174.x.
6
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.2005 年至 2010 年期间，欧洲注射吸毒者中的 HIV 和丙型肝炎病毒感染趋势。
Euro Surveill. 2011 Dec 1;16(48):20031.
7
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.预防环境下注射吸毒者中艾滋病毒和丙型肝炎病毒感染：回顾性队列研究
BMJ. 1998 Aug 15;317(7156):433-7. doi: 10.1136/bmj.317.7156.433.
8
Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.悉尼注射吸毒者中乙肝疫苗接种知识匮乏且接种率低。
Aust N Z J Public Health. 2003 Oct;27(5):558.
9
10
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.1994 - 2004年西雅图18至30岁注射吸毒者中乙肝病毒、丙肝病毒及人类免疫缺陷病毒的流行趋势、危险行为及预防措施
J Urban Health. 2007 May;84(3):436-54. doi: 10.1007/s11524-007-9178-2.
引用本文的文献
1
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?在人类免疫缺陷病毒感染者中消除丙型肝炎病毒：我们目前的进展如何？
World J Hepatol. 2024 May 27;16(5):661-666. doi: 10.4254/wjh.v16.i5.661.
2
Temporal Trends of Infective Endocarditis in North America From 2000 to 2017-A Systematic Review.2000年至2017年北美感染性心内膜炎的时间趋势——一项系统评价
Open Forum Infect Dis. 2021 Sep 25;8(11):ofab479. doi: 10.1093/ofid/ofab479. eCollection 2021 Nov.
3
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.两种病毒的故事：HCV/HIV 合并感染的免疫学见解。
Front Immunol. 2021 Aug 12;12:726419. doi: 10.3389/fimmu.2021.726419. eCollection 2021.
4
Factors associated with injury and blood-borne infection risk when providing assisted injection among people who inject drugs.在为注射吸毒者提供辅助注射时，与伤害和血源性病原体感染风险相关的因素。
Int J Drug Policy. 2021 Nov;97:103297. doi: 10.1016/j.drugpo.2021.103297. Epub 2021 May 30.
5
Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran.伊朗克尔曼注射吸毒人群队列研究中 HIV 和 HCV 发病率测量的失访比例和原因。
Subst Abuse Treat Prev Policy. 2021 Apr 1;16(1):29. doi: 10.1186/s13011-021-00368-9.
6
Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City.纽约市使用毒品的波多黎各人群中的丙型肝炎发病率和流行率。
Glob Public Health. 2020 Dec;15(12):1789-1799. doi: 10.1080/17441692.2020.1768276. Epub 2020 May 19.
7
Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug use.非传染性疾病合并症诊断后的死亡情况，按注射吸毒分层。
AIDS. 2019 Feb 1;33(2):285-293. doi: 10.1097/QAD.0000000000002054.
8
A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone.一项调查美沙酮治疗的阿片类物质使用障碍患者复发预测因素的前瞻性研究。
Subst Abuse. 2016 Apr 10;10:9-18. doi: 10.4137/SART.S37030. eCollection 2016.
9
The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.阿片类药物替代疗法对阿片类药物依赖患者的有效性：一项系统评价和多种治疗比较方案
Syst Rev. 2014 Sep 19;3:105. doi: 10.1186/2046-4053-3-105.
10
Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study.遗传因素对接受美沙酮维持治疗的阿片类药物成瘾患者美沙酮治疗结局的影响：一项初步研究。
Neuropsychiatr Dis Treat. 2014 Aug 19;10:1503-8. doi: 10.2147/NDT.S66234. eCollection 2014.
本文引用的文献
1
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.预防环境下注射吸毒者中艾滋病毒和丙型肝炎病毒感染：回顾性队列研究
BMJ. 1998 Aug 15;317(7156):433-7. doi: 10.1136/bmj.317.7156.433.
2
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.干扰素α-2b联合或不联合利巴韦林治疗慢性丙型肝炎的随机、双盲、安慰剂对照试验。瑞典研究小组。
Lancet. 1998 Jan 10;351(9096):83-7. doi: 10.1016/s0140-6736(97)06088-1.
3
Transmission of hepatitis C virus: rates, routes, and cofactors.
Epidemiol Rev. 1996;18(2):137-48. doi: 10.1093/oxfordjournals.epirev.a017921.
4
Interventions among injecting drug users: do they work?
AIDS. 1995;9 Suppl A:S75-84.
5
Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.阿姆斯特丹人类免疫缺陷病毒（HIV）阳性和HIV阴性吸毒者队列中的死亡率预测因素。
Am J Epidemiol. 1996 Feb 15;143(4):380-91. doi: 10.1093/oxfordjournals.aje.a008752.
6
Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.职业暴露于HIV感染血液的医护人员中HIV感染及齐多夫定使用情况的监测。美国疾病控制与预防中心针刺伤监测协作组。
Ann Intern Med. 1993 Jun 15;118(12):913-9. doi: 10.7326/0003-4819-118-12-199306150-00001.
7
Hepatitis C virus six years on.丙型肝炎病毒六年回顾。
Lancet. 1994 Nov 26;344(8935):1475-9. doi: 10.1016/s0140-6736(94)90293-3.
Zotero 插件